Serum malondialdehyde in HIV seropositive children.

[1]  L. Packer,et al.  Inhibition of NF-κB Activation by Vitamin E Derivatives , 1993 .

[2]  C. Rice-Evans,et al.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. , 1993, Clinical science.

[3]  B. Aggarwal,et al.  α-Lipoic acid is a potent inhibitor of NF-κB activation in human T cells , 1992 .

[4]  F. Müller,et al.  Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. , 1992, Free radical biology & medicine.

[5]  B. Lauterburg,et al.  Glutathione depletion in HIV‐infected patients: role of cysteine deficiency and effect of oral N‐acetylcysteine , 1992, AIDS.

[6]  A. Favier,et al.  High-performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent. , 1992, Journal of chromatography.

[7]  M. Roederer,et al.  N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.

[8]  M. Roederer,et al.  Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. , 1992, AIDS research and human retroviruses.

[9]  H. Eck,et al.  Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques , 1991, The Lancet.

[10]  H. Rollag,et al.  Reduced oxidative burst responses in monocytes and monocyte‐derived macrophages from HIV‐infected subjects , 1990, Clinical and experimental immunology.

[11]  M. Roederer,et al.  Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Crystal,et al.  SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.

[13]  G. Knapp,et al.  Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) , 1988, The New England journal of medicine.

[14]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1987, Nature.

[15]  K. Schwarz,et al.  Oxidative stress during viral infection: a review. , 1996, Free radical biology & medicine.

[16]  W. Dröge,et al.  Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine. , 1993, Pharmacology.

[17]  A. Sönnerborg,et al.  Increased production of malondialdehyde in patients with HIV infection. , 1988, Scandinavian journal of infectious diseases.